Bio-Thera Signs Latin American Partnership Deal For Two Undisclosed Biosimilars

The Deal Gives Latin American Rights To Regional Player SteinCares

The Chinese firm announced a new deal with Costa Rican company SteinCares that handed over the rights to two unnamed biosimilars in the region for an undisclosed sum.

The Brazilian flag painted on white paper with watercolor
• Source: Shutterstock

The Chinese company Bio-Thera Solutions has signed a partnership deal with specialty healthcare company SteinCares over commercialization rights for two biosimilars in Brazil and the rest of Latin America.

Bio-Thera did not specify in its announcement what biosimilars are included as part of this deal that gives the Costa...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.